CLVS
Clovis Oncology, Inc.
CLVS
CLVS
Delisted
CLVS was delisted on the 20th of December, 2022.
147 hedge funds and large institutions have $358M invested in Clovis Oncology, Inc. in 2019 Q4 according to their latest regulatory filings, with 36 funds opening new positions, 36 increasing their positions, 50 reducing their positions, and 41 closing their positions.
New
Increased
Maintained
Reduced
Closed
more funds holding in top 10
Funds holding in top 10: →
more capital invested
Capital invested by funds: $ → $
less call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
12% less first-time investments, than exits
New positions opened: 36 | Existing positions closed: 41
28% less repeat investments, than reductions
Existing positions increased: 36 | Existing positions reduced: 50
Holders
147
Holding in Top 10
2
Calls
$114M
Puts
$118M
Top Buyers
| 1 | +$27.8M | |
| 2 | +$6.55M | |
| 3 | +$5.21M | |
| 4 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$3.5M |
| 5 |
Jane Street
New York
|
+$2.54M |
Top Sellers
| 1 | -$26M | |
| 2 | -$15.7M | |
| 3 | -$15.2M | |
| 4 |
RG
Redmile Group
San Francisco,
California
|
-$14.2M |
| 5 |
D.E. Shaw & Co
New York
|
-$13.9M |